Dr. Alsuwaidan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 N 30th St
Omaha, NE 68131Phone+1 402-280-3436Fax+1 402-280-5247- Is this information wrong?
Education & Training
Creighton University School of Medicine (Omaha)Residency, Pathology-Anatomic and Clinical, 2013 - 2017
King Faisal University College of MedicineClass of 2006
Certifications & Licensure
PA State Medical License 2016 - 2022
NE State Medical License 2016 - 2018- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 2 citationsA Combined Biomarker of Bright CD38 and MYC ≥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma.Abdullah Alsuwaidan, Prasad Koduru, Franklin Fuda, Jesse Manuel Jaso, Mingyi Chen, Flavia Rosado, Hung S Luu, Nathan Sweed, Rolando Garcia, Meggie Doucet, Neil B Desai...> ;American Journal of Clinical Pathology. 2022 Sep 2
- 18 citationsBright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High SpecificityAbdullah Alsuwaidan, Elaina Pirruccello, Jesse Jaso, Prasad Koduru, Rolando Garcia, Jo Ellen Krueger, Meggie Doucet, Rahman Chaudhry, Franklin Fuda, Weina Chen> ;Cytometry. Part B, Clinical Cytometry. 2019 Sep 1
- Flow Cytometric Features in Double/Triple Hit Lymphomas: Dim CD45 Expression of Limited Diagnostic UtilityXiang Xu, Franklin Fuda, Abdullah Alsuwaidan, Jesse Jaso, Weina Chen> ;Cytometry. Part B, Clinical Cytometry. 2019 Jul 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
